Cargando…

Impact of Impulsivity, Hyperactivity, and Inattention on Discontinuation Rate among Opioid-Dependent Patients Treated with Extended-Release Naltrexone

Previous studies have indicated elevated levels of impulsivity, hyperactivity, and inattention (IHI) among opioid-dependent patients seeking outpatient treatment with extended-release naltrexone (XR-NTX). This led us to hypothesize that IHI may be associated with a higher discontinuation rate for XR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karlsson, Ann Tarja, Vederhus, John-Kåre, Clausen, Thomas, Weimand, Bente, Solli, Kristin Klemmetsby, Tanum, Lars
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9517108/ https://www.ncbi.nlm.nih.gov/pubmed/36141709 http://dx.doi.org/10.3390/ijerph191811435

Ejemplares similares

Levels of Impulsivity, Hyperactivity, and Inattention and the Association with Mental Health and Substance Use Severity in Opioid-Dependent Patients Seeking Treatment with Extended-Release Naltrexone
por: Karlsson, Ann Tarja, et al.
Publicado: (2021)

Personal recovery among people with opioid use disorder during treatment with extended-release naltrexone
por: Marciuch, Anne, et al.
Publicado: (2023)

Patients’ experiences of continued treatment with extended-release naltrexone: a Norwegian qualitative study
por: Marciuch, Anne, et al.
Publicado: (2022)

Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX)
por: Kunøe, Nikolaj, et al.
Publicado: (2016)

Adapting treatment length to opioid‐dependent individuals’ needs and preferences: a 2‐year follow‐up to a 1‐year study of extended‐release naltrexone
por: Solli, Kristin Klemmetsby, et al.
Publicado: (2021)

Enablers and hindrances for longer-term abstinence in opioid dependent individuals receiving treatment with extended-release naltrexone: A Norwegian longitudinal recovery trial (NaltRec study)
por: Weimand, B.M., et al.
Publicado: (2021)

Discrepancy in Ratings of Shared Decision Making Between Patients and Health Professionals: A Cross Sectional Study in Mental Health Care
por: Drivenes, Karin, et al.
Publicado: (2020)

Self-Concept and Inattention or Hyperactivity–Impulsivity Symptomatology: The Role of Anxiety
por: Cueli, Marisol, et al.
Publicado: (2020)

Statistical Evidence Suggests that Inattention Drives Hyperactivity/Impulsivity in Attention Deficit-Hyperactivity Disorder
por: Sokolova, Elena, et al.
Publicado: (2016)

Temperamental predictors of developmental trajectories of inattention and hyperactivity–impulsivity problems in schoolchildren
por: Lee, Soo Jin, et al.
Publicado: (2017)

Dissociation in Neural Correlates of Hyperactive/Impulsive vs. Inattentive Symptoms in Attention-Deficit/Hyperactivity Disorder
por: Luo, Yu, et al.
Publicado: (2022)

Substance use in young adults with ADHD: Comorbidity and symptoms of inattention and hyperactivity/impulsivity
por: Miranda, Ana, et al.
Publicado: (2016)

Characterizing the heterogeneous course of inattention and hyperactivity-impulsivity from childhood to young adulthood
por: Vos, Melissa, et al.
Publicado: (2021)

Inattention, Impulsivity, and Hyperactivity among Individuals with Self-Reported Impaired Wound Healing
por: Balikji, Jessica, et al.
Publicado: (2022)

Perceived family cohesion, social support, and quality of life in patients undergoing treatment for substance use disorders compared with patients with mental and physical disorders
por: Birkeland, Bente, et al.
Publicado: (2021)

The Impact of Inattention, Hyperactivity/Impulsivity Symptoms, and Executive Functions on Learning Behaviors of Children with ADHD
por: Colomer, Carla, et al.
Publicado: (2017)

Perceived quality of life in partners of patients undergoing treatment in somatic health, mental health, or substance use disorder units: a cross-sectional study
por: Birkeland, Bente, et al.
Publicado: (2017)

Hyperactivity, impulsivity, and inattention in boys with cleft lip and palate: relationship to ventromedial prefrontal cortex morphology
por: Nopoulos, Peggy, et al.
Publicado: (2010)

Correlations of gene expression with ratings of inattention and hyperactivity/impulsivity in tourette syndrome: a pilot study
por: Tian, Yingfang, et al.
Publicado: (2012)

Naltrexone extended-release injection: an option for the management of opioid abuse
por: Taylor, Robert, et al.
Publicado: (2011)

Inattention, Impulsivity, and Hyperactivity in Deaf Children Are Not Due to Deficits in Inhibitory Control, but May Reflect an Adaptive Strategy
por: Daza González, María Teresa, et al.
Publicado: (2021)

Canine hyperactivity, impulsivity, and inattention share similar demographic risk factors and behavioural comorbidities with human ADHD
por: Sulkama, Sini, et al.
Publicado: (2021)

Perceived quality of life, 6 months after detoxification: Is abstinence a modifying factor?
por: Vederhus, John-Kåre, et al.
Publicado: (2016)

High smoking and low cessation rates among patients in treatment for opioid and other substance use disorders
por: Bjørnestad, Endre Dahlen, et al.
Publicado: (2022)

Probe-caught spontaneous and deliberate mind wandering in relation to self-reported inattentive, hyperactive and impulsive traits in adults
por: Arabacı, Gizem, et al.
Publicado: (2018)

Inattention and hyperactive/impulsive component scores do not differentiate between autism spectrum disorder and attention-deficit/hyperactivity disorder in a clinical sample
por: Krakowski, Aneta D., et al.
Publicado: (2020)

Eating problems in ADHD: self-regulatory or inattentive/impulsive
por: Araújo, A., et al.
Publicado: (2022)

The influence of participation in target-shooting sport for children with inattentive, hyperactive and impulsive symptoms – A controlled study of best practice
por: Månsson, Annegrete Gohr, et al.
Publicado: (2017)

Yoga and music intervention reduces inattention, hyperactivity/impulsivity, and oppositional defiant disorder in children’s consumer with comorbid ADHD and ODD
por: Luo, Xue, et al.
Publicado: (2023)

The Role of Impulsivity, Inattention and Comorbid ADHD in Patients with Bulimia Nervosa
por: Seitz, Jochen, et al.
Publicado: (2013)

Treating Opioid Dependence With Injectable Extended-Release Naltrexone (XR-NTX): Who Will Respond?
por: Nunes, Edward V., et al.
Publicado: (2015)

Naltrexone Implant for Opioid Use Disorder
por: Edinoff, Amber N., et al.
Publicado: (2021)

Predicting patient post-detoxification engagement in 12-step groups with an extended version of the theory of planned behavior
por: Vederhus, John-Kåre, et al.
Publicado: (2015)

Motivational intervention to enhance post-detoxification 12-Step group affiliation: a randomized controlled trial
por: Vederhus, John-Kåre, et al.
Publicado: (2014)

Medication Treatment for Opioid Use Disorders:: A Brief Overview with Comments on Extended Release Naltrexone
por: Woody, George
Publicado: (2017)

Developmental Predictors of Inattention-Hyperactivity from Pregnancy to Early Childhood
por: Foulon, Stéphanie, et al.
Publicado: (2015)

Inattention and hyperactivity symptoms in childhood predict physical activity in adolescence
por: Selinus, Eva Norén, et al.
Publicado: (2021)

Effectiveness of Online Mindfulness-Based Intervention (iMBI) on Inattention, Hyperactivity–Impulsivity, and Executive Functioning in College Emerging Adults with Attention-Deficit/Hyperactivity Disorder: A Study Protocol
por: Pheh, Kai-Shuen, et al.
Publicado: (2021)

Open-label Study of Injectable Extended-release Naltrexone (XR-NTX) in Healthcare Professionals With Opioid Dependence
por: Earley, Paul H., et al.
Publicado: (2017)

The relationship between reincarceration and treatment of opioid use disorder with extended-release naltrexone among persons with HIV
por: Parchinski, Kaley, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_igg4s85jfsdtuq1h2gulhn5pcj